Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Informed consent
Otherwise healthy outpatient with mountain cedar allergy
Male or eligible female Females of childbearing potential must commit to the consistent and correct use of an acceptable method of birth control
Age 12 years or older at Visit 2
Diagnosis of seasonal allergic rhinitis (SAR) to mountain cedar
Adequate exposure to mountain cedar pollen
Ability to comply with study procedures
Literate
You may not be if
Significant concomitant medical conditions
Use of intranasal corticosteroids within four weeks prior to Visit 1; use of inhaled, oral, intramuscular, intravenous, ocular, and/or dermatological corticosteroid (with the exception of hydrocortisone cream/ointment, 1% or less) within eight weeks prior to Visit 1.
Use of other allergy medications within specific timeframes relative to Visit 1
Use of other medications that may affect allergic rhinitis or its symptoms
Use of immunosuppressive medications eight weeks prior to screening and during the study
Immunotherapy patients who are not stable on current dose
Use of any medications that significantly alters the pharmacokinetics of fluticasone furoate or fexofenadine
Allergy/Intolerance to corticosteroids, antihistamines, or any excipients in the two products
Use of contact lenses
Recent clinical trial/experimental medication experience within 30 days of Visit 1
Subject previously failed the 21-day screen period or failed to complete the treatment period
Positive or inconclusive pregnancy test or female who is breastfeeding
Employee or relative affiliation with investigational site
Current tobacco use
Active chickenpox or measles or exposure in the last 3 weeks
Clareo Health | Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
